We have developed a facile, scalable method for preparation of enzyme responsive copolypeptide vesicles that requires no protecting groups or expensive components. We designed amphiphilic copolypeptides containing segments of water soluble methionine sulfoxide, M O , residues that were prepared by synthesis of a fully hydrophobic precursor diblock copolypeptide, poly(L-methionine) 65 -b-poly(L-leucine 0.5 -stat-L-phenylalanine 0.5 ) 20 , M 65 (L 0.5 /F 0.5 ) 20 , followed by its direct oxidation in water to give the amphiphilic M O derivative, M O 65 (L 0.5 /F 0.5 ) 20 . Assembly of M O 65 (L 0.5 /F 0.5 ) 20 in water gave vesicles with average diameters of a few microns that could then be extruded to nanoscale diameters. The M O segments in the vesicles were found to be substrates for reductase enzymes, which regenerated hydrophobic M segments and resulted in a change in supramolecular morphology that caused vesicle disruption and release of cargos.
Introduction
Stimuli responsive polymeric assemblies provide advantages for many applications, including triggered intracellular release of cargos for drug delivery. Enzyme responsive materials are especially advantageous since they not only utilize the high specificity of enzymes, they can also respond selectively to local biological environments, such as diseased or injured tissues.
However, construction of such materials often requires use of complex components and multiple chemical steps. We have developed a facile, scalable method for preparation of enzyme responsive copolypeptide vesicles that requires no protecting groups or expensive components.
These materials utilize cell compatible polymers and were found to be excellent substrates for ubiquitous intracellular reductases. This unprecedented enzymatic vesicle reduction caused changes in chain conformations and solubility that resulted in vesicle rupture and release of encapsulated cargos. These fully synthetic materials showcase a new type of enzyme responsive polymer that provides an innovative mechanism for disruption of self assemblies.
Enzyme responsive materials (ERMs) show much promise and are receiving increasing attention since they allow synthetic materials to interface with biological systems, and can utilize the specificity, selectivity, and high catalytic efficiency of enzymes to alter material properties. 1 Numerous ERMs have been developed based on hydrogel or micelle structures, which can be switched between assembled and disassembled forms using enzymes under mild conditions. 1, 2 Although many different enzymes and substrates have been used in ERMs, most of these rely on bond formation or cleavage reactions that primarily employ proteases, nucleases, or kinases/phosphatases. 1 In contrast, there are few examples of ERMs that utilize other types of enzymatic reactions, such as oxidations/reductions where only chemical responsive systems have been reported. 3, 5 Many ERMs also utilize specific peptide or oligonucleotide sequences as enzyme substrates, 1,2 which in turn increases the cost and complexity of ERM preparation. To enable widespread use of ERMs in various applications, such as diagnostics, sensors, drug delivery, adaptive surfaces, and regenerative medicine, it would be advantageous to be able to create ERMs that respond to different classes of enzymatic reactions, and that can be prepared using atom economical, scalable methods.
Polymer vesicles are attractive nanocarriers since they have high stability compared to liposomes, and contrary to micelles, are able to encapsulate both hydrophilic and hydrophobic cargos. 6 Although many stimuli responsive polymer vesicles (e.g. to pH, temperature, light) have been prepared, no enzyme responsive vesicles have been reported. 7 Such ERM properties would be useful in adding specific mechanisms for vesicles to interact with cells and biological systems, such as enzyme triggered assembly or disassembly. Our lab has been interested in developing block copolypeptide vesicles since they possess the attractive features of biodegradability, tunable properties, and ability to incorporate the functionality of proteins via a scalable synthetic process. 8, 9 We sought to utilize this inherent functionality of polypeptide segments to introduce enzyme responsive properties into vesicles. Although the degradation of synthetic polypeptides by enzymes is well known (e.g. trypsin digestion of poly(L-lysine)), 10 this strategy was not pursued for ERM development since such peptidolysis is essentially a biodegradation process rather than a triggered response.
Experimental
Materials and general procedures Anhydrous tetrahydrofuran (THF), hexane and diethyl ether were prepared by passage through alumina columns, and oxygen was removed by purging solvents with nitrogen prior to use. 1 H NMR spectra were recorded on a Bruker AVANCE 400 MHz spectrometer. All Fourier Transform Infrared (FTIR) samples were prepared as thin films on NaCl plates and spectra were recorded on a Perkin Elmer RX1 FTIR spectrometer and are reported in terms of frequency of absorption (cm -1 ). Tandem gel permeation chromatography/light scattering (GPC/LS) was performed on a SSI Accuflow Series III liquid chromatograph pump equipped with a Wyatt DAWN EOS light scattering (LS) and Optilab rEX refractive index (RI) detectors. Separations were achieved using 10 5 , 10 4 , and 10 3 Å Phenomenex Phenogel 5 µm columns using 0.10 M LiBr in DMF as the eluent at 60 °C. All GPC/LS samples were prepared at concentrations of 5 mg/mL. Millipore (18 MΩ) water was obtained from a Millipore Milli-Q Biocel A10 purification unit.
Synthesis All α-amino acid-N-carboxyanhydride (NCA) monomers were synthesized using previously described protocols. 11 L-Phenylalanine and L-leucine NCAs were synthesized by phosgenation and purified by recrystallization. L-Methionine NCA was prepared by phosgenation and purified by anhydrous column chromatography. 12 α-Methoxy-ω-isocyanoethylpoly(ethylene glycol) 45 (mPEG 45 -NCO) was prepared by reacting α-methoxy-ω-aminoethylpoly(ethylene glycol) 45 (mPEG 45 -NH 2 , M n = 2000 g mol -1 , Nanocs) with phosgene in THF for 16 h. 12 All block copolypeptides were synthesized using (PMe 3 ) 4 Co initiator. 13 Preparation of copolypeptide vesicles Copolypeptide powder, M O 65 (L 0.5 /F 0.5 ) 20 , was dispersed in THF to give a 1 % (w/v) suspension. The suspension was placed in a bath sonicator for 30 minutes to evenly disperse the copolypeptide and reduce large particulates. An equivalent volume of Millipore water was then added to give a 0.5 % (w/v) suspension. The suspension became clear as the sample was mixed by vortex. The mixture was then dialyzed (2,000 MWCO) against Millipore water overnight with three water changes, yielding the copolypeptide vesicle suspension. were diluted with Millipore water to 0.2 % (w/v) and extruded using an Avanti Mini-Extruder.
Extrusion of copolypeptide vesicles
Extrusions were performed using different pore size Whatman Nucleopore Track-Etched polycarbonate (PC) membranes, following a protocol of serial extrusion through decreasing filter pore sizes: 3 times through a 1.0 μm filter, 3 times through a 0.4 μm filter, 3 times through a 0.2 μm filter, and 3 times through a 0.1 μm filter. The PC membranes and filter supports were soaked in Millipore water for 10 minutes prior to extrusion. 
Enzymatic reduction of M

Results and Discussion
In an effort to create enzyme responsive polypeptide assemblies, we designed amphiphilic copolypeptides containing segments of oxidized methionine residues, which occur naturally when methionine containing proteins are exposed to reactive oxygen species (ROS).
Methionine oxidation in proteins is well known and is believed to help maintain protein activity since these residues act as sacrificial substrates for ROS, preventing irreversible oxidation at critical active site residues such as cysteines. [15] [16] [17] Methionine residues ,are particularly effective ROS scavengers, able to consume ROS catalytically since their oxidation is reversible via the methionine sulfoxide reductase A and B (MSR) enzymes that are found within cells throughout the human body. 18, 19 The two MSR enzymes reduce different diastereomers of methionine sulfoxide that arise from sulfoxide group chirality. 19 The possibility to interchange methionine residues between hydrophobic (reduced) and hydrophilic (oxidized) states under biological conditions inspired us to incorporate poly(Lmethionine), M, segments into copolypeptide vesicle assemblies. 12 Block copolymers containing oxidized M segments have not been previously reported. To evaluate their suitability for use in amphiphilic copolymers, we prepared a poly(L-methionine) 80 (Figure 1a ). 20 While M is α-helical and hydrophobic (Figure 1b ), 21 M O is known to be highly water soluble and was observed by circular dichroism spectroscopy (CD) to be completely disordered (Figure 1c ). 22 Although the sulfone group is more polar than the sulfoxide, 23 the previously unreported, fully oxidized M O2 80 was observed by CD to be predominantly α-helical ( Figure 1d ) and only marginally water soluble, likely due to interactions between sulfone groups and crystallization of the helices. 23, 24 The water solubility and disordered conformation of M O make it an ideal candidate hydrophilic segment for use in vesicle preparation. 8, 9, 11 The homopolypeptide M O has also been reported to be non-toxic at 2.0 g/kg when administered intravenously in mice, 25 and we have found that M O is digested by proteinase K, indicating it is also biodegradable (see supporting information, SI). Table S1 ). 13 The segment lengths were based on those previously found to promote vesicle formation using other amino acids, 8, 9, 11 and phenylalanine was incorporated within the rod-like, permanently hydrophobic leucine segment to enhance membrane flexibility. 26 Subsequent mild oxidation of this hydrophobic precursor with hydrogen peroxide directly gave the desired amphiphilic methionine sulfoxide derivative, M O 65 (L 0.5 /F 0.5 ) 20 , in high yield and purity (Figure 2 ). 20 Due to its use in animal feeds, more methionine is produced chemically than any other amino acid, 27 which lowers its cost and makes this route a very economical process for synthesis of amphiphilic copolypeptides. Assembly of M O 65 (L 0.5 /F 0.5 ) 20 in water using mixed solvent annealing followed by dialysis gave polydisperse vesicles with average diameters of a few microns, 11 as determined by optical microscopy and laser scanning confocal microscopy (LSCM) (Figure 3a,b) . These vesicles formed stable suspensions that did not aggregate or precipitate over time in aqueous media, and possessed slightly negative zeta potentials across a broad pH range (see SI, Figure S1 ). For use in blood circulation where nanoscale diameters are required, the vesicles can be reduced in size by extrusion through polycarbonate filters to give nanoscale vesicles with average diameters of ca. 100 nm as determined by TEM, cryo-TEM and dynamic light scattering (DLS) (Figure 3c ,d, see SI, Table S2 ). Overall, M O was found to serve as an excellent hydrophilic segment for creation of stable, copolypeptide vesicles of controllable size.
Beyond these attractive properties, we also wanted to test if M O segments are able to serve as good substrates for reduction by MSR enzymes. Since conversion of M O to M would result in a conformational change and a decrease in hydrophilicity, successful enzymatic reduction of M O 65 (L 0.5 /F 0.5 ) 20 vesicles could lead to a triggered change in self-assembled morphology. 2 Oxidation and reduction of carefully positioned methionine residues have been used previously to alter chain conformations of specific peptide and protein sequences, yet these transformations were accomplished only via chemical treatments. 28, 29 Although intracellular MSR enzymes are known to efficiently catalyze the thioredoxin dependent reduction of monomeric and protein bound methionine sulfoxide to methionine, 19 to our knowledge the reduction of methionine sulfoxide residues in synthetic polypeptides using MSR enzymes has not been demonstrated. To assess their ability to act as viable enzyme substrates, we incubated M O 65 (L 0.5 /F 0.5 ) 20 vesicles with MSR enzymes and DTT, which was used as a surrogate reductant in place of thioredoxin. 14 Samples were observed to be unchanged when incubated with DTT alone, but the vesicles formed precipitates when incubated with both DTT and MSR enzymes at 37 ºC for 16h (Figure 4a containing additional segments or functionality for increased cell uptake can be accomplished using established procedures. 31, 32 The oxidized nature of M O vesicles should also allow them to remain stable and intact extracellularly, as well as in oxidatively stressed environments, which are commonly found in injury, cancer and other diseases. Since evidence shows that thioredoxin and MSR enzymes are upregulated by cells in areas of oxidative stress, 33 the selectivity of MSR enzymes for M O vesicle reduction may also provide a means for targeted cargo release in oxidatively stressed tissues.
Conclusions
Here we have shown that use of non-toxic M O segments in copolypeptide vesicle nanocarriers imparts these materials with many advantageous properties, including good solubility, ability to degrade into natural metabolites, and enzyme responsiveness that permits the unprecedented utilization of common intracellular enzymes to promote vesicle disruption and release of encapsulated cargos. These properties make biocompatible and readily prepared M O an attractive new class of stimulus responsive polymer, 34 which is sensitive to enzymatic reduction and differs from other enzyme responsive materials that typically utilize coupling or cleavage reactions. 1 The structural simplicity of M O , combined with its economical synthesis and exceptional properties, enable its application to a broad range of stimuli responsive synthetic material challenges. 
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